Paper36978212
The effect of statin medication on the incidence of oral squamous cell carcinoma among betel-nut chewers.
Huang CC and 4 others. Head Neck, 2023. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. The effect of statin medication on the incidence of oral squamous cell carcinoma among betel-nut chewers. Papers, record 36978212. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36978212
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The effect of statin medication on the incidence of oral squamous cell carcinoma among betel-nut chewers.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mouth Neoplasms | Major topic |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | Major topic |
| Carcinoma, Squamous Cell | Major topic |
| Head and Neck Neoplasms | Major topic |
| Humans | |
| Areca | |
| Incidence | |
| Squamous Cell Carcinoma of Head and Neck | |
| Nuts |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42919165 | A disease-specific immunonutritional model for prognostic stratification in oral cavity squamous cell carcinoma. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42919165 | PubMed |
| 42307682 | Repurposing statins for the management of head and neck squamous cell carcinoma: A systematic review of preclinical and clinical evidence. | Med Oncol | 2026 | https://conductscience.org/library/papers/42307682 | PubMed |
| 39803639 | Aspirin use reduces cancer risk in betel nut chewers: a nationwide population-based cohort study. | Am J Cancer Res | 2024 | https://conductscience.org/library/papers/39803639 | PubMed |
| 39767804 | The Prognostic Value of Preoperative Total Cholesterol in Surgically Treated Oral Cavity Cancer. | Biomedicines | 2024 | https://conductscience.org/library/papers/39767804 | PubMed |
| 39198807 | A novel nomogram for predicting overall survival in patients with tongue squamous cell carcinoma using clinical features and MRI radiomics data: a pilot study. | World J Surg Oncol | 2024 | https://conductscience.org/library/papers/39198807 | PubMed |
| 38978394 | Chemoprevention of Head and Neck Cancer: A Review of Current Approaches and Future Perspectives. | Cancer Prev Res (Phila) | 2024 | https://conductscience.org/library/papers/38978394 | PubMed |
| 38611874 | Advances in Small Molecular Agents against Oral Cancer. | Molecules | 2024 | https://conductscience.org/library/papers/38611874 | PubMed |
| 37872687 | Prediction of Prognosis of Tongue Squamous Cell Carcinoma Based on Clinical MR Imaging Data Modeling. | Technol Cancer Res Treat | 2023 | https://conductscience.org/library/papers/37872687 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36978212
GET https://conductscience.org/api/papers/v1/36978212/authors